Synchronous Occurrence of Ovarian Seromucinous Carcinoma and Endometrial Mucinous Carcinoma: A Case Report
| Autor: | Taeko Ueda, Hiroshi Harada, Masanori Hisaoka, Kiyoshi Yoshino, Takatoshi Aoki, Ryuji Iwamura, Atsushi Tohyama, Jun Tsukamoto, Kaori Hoshino, Yusuke Matsuura, Yoko Aoyama, Yasuyuki Kinjo, Ruka Urakawa, Seiji Kagami |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Pleural effusion 03 medical and health sciences 0302 clinical medicine medicine Carcinoma Mucinous carcinoma Humans Ovarian Neoplasms medicine.diagnostic_test business.industry Endometrial cancer Public Health Environmental and Occupational Health General Medicine Middle Aged medicine.disease Debulking Adenocarcinoma Mucinous female genital diseases and pregnancy complications Endometrial Neoplasms 030220 oncology & carcinogenesis Adenocarcinoma Female Radiology Neoplasm Recurrence Local business Ovarian Seromucinous Carcinoma Carcinoma Endometrioid 030217 neurology & neurosurgery Endometrial biopsy |
| Zdroj: | Journal of UOEH. 43(2) |
| ISSN: | 0387-821X |
| Popis: | Endometrioid carcinoma is the most common histological type of concurrent synchronous cancers of the uterus and ovary. Here we report a case of synchronous seromucinous carcinoma of the ovary and mucinous carcinoma of the endometrium with a literature review. A 51-year-old multiparous female complained of irregular bleeding and shortness of breath. Computed tomography revealed a large pelvic mass that consisted of cystic and solid components, a tumor of the endometrium, and a large amount of pleural effusion. An endometrial biopsy indicated adenocarcinoma, and adenocarcinoma cells were found in the pleural fluid. The patient with advanced ovarian cancer or endometrial cancer with massive pleural effusion received three courses of neoadjuvant chemotherapy (NAC) with paclitaxel and carboplatin followed by interval debulking surgery (IDS). The NAC was effective, and IDS was performed with no gross residual lesions. The post-operative diagnosis was seromucinous carcinoma of the ovary in FIGO (2014) stage IVA (ypT3cNxM1a) and mucinous carcinoma of the endometrium in FIGO (2008) stage IA (ypT1aNXM0). Three courses of postoperative TC therapy were performed, and maintenance therapy with Bevacizumab is ongoing. The patient is well without evidence of recurrence, sixteen months after surgery. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|